Vifor Pharma, Cara Therapeutics to commercialise kidney disease drug Korsuva in US

Vifor Pharma and Cara Therapeutics have agreed to commercialise kidney disease drug Korsuva in the US. (Credit: Riki Risnandar from Pixabay)